Skip to content
Screener

BioLife Solutions BLFS Q1 2026 Annual earnings

Reported May 7, 2026 · After market close

Revenue$27.5MBeat by $1.8M
EPS$0.04Beat by $0.03
Revenue estimate$25.7M
EPS estimate$0.01

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$29.2M
EPS estimate$0.01

Financials

Q1 2026

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02—

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$921.56M-14.0%
Enterprise value$916.1M-11.2%
P/S9.4×-4.3×

Profitability

See full
Operating margin-16.6%—

Returns & leverage

See full
Debt / equity0×0.0×
Current ratio7.3×+2.6×

FAQ

When did BioLife Solutions report Q1 2026 earnings?
BioLife Solutions (BLFS) reported Q1 2026 earnings on May 7, 2026 after market close.
What were BioLife Solutions's Q1 2026 revenue and EPS?
BioLife Solutions reported revenue of $27.5M and eps of $0.04 for Q1 2026.
Did BioLife Solutions beat estimates in Q1 2026?
Revenue beat the consensus estimate of $25.7M by $1.8M. EPS beat the consensus estimate of $0.01 by $0.03.
How did BioLife Solutions's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 14.9% from $23.9M a year earlier and eps grew 0.0% from $0.04.
Where can I find BioLife Solutions's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-032123) and the 10-K/A periodic report (0001628280-26-028012) directly on SEC EDGAR. The filing index links above go to sec.gov.